Rationalizing Investigations in Diagnosis of PCOS

Abstract

Polycystic ovarian syndrome is most common endocrinopathy affecting women, with prevalence estimated between 8and 13%, depending on definition used and the population studied.It presents with several possible combinations of signs and symptoms and a wide range of phenotypes, which may include reproductive, endocrine and metabolic abnormalities. Despite of so many available guidelines, there still exists controversies in the diagnosis of PCOS particularly which androgen to measure and which method to use along with pertinent USG findings. This article aims to address various controversies andprovideconsensusin investigations during the diagnosis of polycystic ovary syndrome.